Medium materiality6/10
Neurocrine price target raised to $183 from $182 at Morgan Stanley
Why it may matterVerify against the original reporting
Target uptick signals modest upside potential.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Morgan Stanley raises NBIX target to $183; price $156.57
- NBIX target raised to $183 by Morgan Stanley
Key facts
- 01
Target: $183
- 02
Posted price: $156.57
- 03
Analyst firm: Morgan Stanley
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.